Mahesan Subramaniam: A Visual Guide to Heart Valve Disease
Mahesan Subramaniam, Co-Founder of United Health Tourism, shared a post on LinkedIn:
”A Visual Guide to Heart Valve Disease:
As the most common valvular heart disease, aortic stenosis restricts critical blood flow, turning routine fatigue into a sign of severe cardiac risk.
Aortic valve stenosis (AS) is a serious cardiac condition characterized by the narrowing of the valve that regulates blood flow from the heart’s left chamber to the rest of the body. Often driven by age-related calcium buildup or congenital defects, this condition causes the valve to become stiff and rigid, significantly obstructing circulation. Because symptoms like shortness of breath, fatigue, and chest pain are frequently dismissed as typical signs of aging, many patients remain undiagnosed until the disease reaches a critical stage. Left untreated, the restricted blood flow places immense strain on the heart, eventually leading to heart failure or sudden cardiac events.
Early detection is vital, as the disease progresses from asymptomatic stages to severe impairment requiring medical intervention. Fortunately, advancements in cardiac care have revolutionized how AS is managed, offering hope beyond traditional open-heart surgery. While surgical aortic valve replacement (SAVR) remains a standard, minimally invasive options like Transcatheter Aortic Valve Replacement (TAVR) allow for valve repair with significantly reduced recovery times. By recognizing heart palpitations or fainting spells early, patients can access life-saving treatments that restore blood flow and enhance long-term heart health.
Source
Mayo Clinic. (2023). Aortic valve stenosis. Mayo Foundation for Medical Education and Research.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines